Congratulations to the winners of the 2016 Steve Miller Fellowship in Medical Education.
The Sohn Conference Foundation has announced a three-year, $1.5 million grant to Columbia University Medical Center in support of the center's precision pediatric cancer program.
In phase I/II trial, new targeted therapy for hard-to-treat chronic lymphocytic leukemia appears as effective as ibrutinib with fewer side effects.
CUMC Debuts Program for Those with Undiagnosed Disorders
Parents sometimes know there’s something wrong with their child, but the child’s constellation of symptoms doesn’t add up to a recognized diagnosis. The symptoms can make life difficult, but so can the lack of a diagnosis—and the treatment and support that go with it.
Researchers from Columbia University Medical Center (CUMC), the Pediatric Cardiac Genetics Consortium, and the Pediatric Heart Network have found a number of genetic mutations that explain why many children with congenital heart disease also have other significant health challenges, including neurodevelopmental disorders and other congenital problems. Read more.